Use of alprenolol in the secondary prevention of myocardial infarction.
D000367:Age Factors; D000368:Aged; D000526:Alprenolol / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003645:Death, Sudden / Q000517:prevention & control; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011897:Random Allocation; D012306:Risk; D013997:Time Factors
D000526:Alprenolol